Randi Albin

Title: Randi Albin - Innovator in Pharmaceutical Compositions

Introduction

Randi Albin is a notable inventor based in North Bergen, NJ (US). She has made significant contributions to the field of pharmaceutical compositions, particularly in the development of formulations that enhance analgesia and anesthesia while minimizing neurotoxicity.

Latest Patents

Randi Albin holds a patent for an NMDA receptor antagonist formulation with reduced neurotoxicity. This invention is directed towards pharmaceutical compositions that include effective amounts of NMDA receptor antagonists and preservatives. The formulations are designed for administration to patients in need of effective analgesia and anesthesia, while ensuring that they do not cause significant neurotoxicity. The preferred NMDA receptor antagonist identified in her patent is ketamine, and the preservative used is benzalkonium chloride. She has 1 patent to her name.

Career Highlights

Randi Albin is associated with Innovative Drug Delivery Systems, Inc., where she continues to work on advancing drug delivery technologies. Her expertise in pharmaceutical formulations has positioned her as a key player in the industry.

Collaborations

Randi collaborates with Fred H Mermelstein, contributing to innovative projects within her company.

Conclusion

Randi Albin's work in developing NMDA receptor antagonist formulations showcases her commitment to improving patient care through innovative pharmaceutical solutions. Her contributions are vital in the ongoing quest for safer and more effective medical treatments.